טוען...
Can GPR4 Be a Potential Therapeutic Target for COVID-19?
Coronavirus disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in late 2019 and has since rapidly become a global pandemic. SARS-CoV-2 infection causes damages to the lung and other organs. The clinical manifestations of COVID-19 range widely...
שמור ב:
| הוצא לאור ב: | Front Med (Lausanne) |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7859652/ https://ncbi.nlm.nih.gov/pubmed/33553219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.626796 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|